CD1D and cancer: On the other hand, CD1d-restricted iNKT cells play a pivotal role in tumor immunosurveillance (34, 35), and mounting evidence supports their crucial involvement in impeding tumor progression by inducing proinflammatory and immunostimulatory programs in myelomonocytic cells, irrespective of CD1d expression by cancer cells (36, 37).